Hathal Haddad Shares Key Takeaways from the GEC-ESTRO Annual Workshop 2026
Hathal Haddad/LinkedIn

Hathal Haddad Shares Key Takeaways from the GEC-ESTRO Annual Workshop 2026

Hathal Haddad, Head of Interventional Radiotherapy Unit at the Department of Radiation Oncology at University Hospital Tübingen, shared on LinkedIn:

“Recognition for a Urologist Who Believes in Interventional Radiotherapy (Brachytherapy) for Prostate Cancer!

Highlights from Day 1 at the GEC-ESTRO Annual Workshop 2026 in Seville, Spain. GEC-ESTRO Recognition Award.

Congratulations to Prof. Stefan Machtens, a dedicated urologist and strong advocate for interventional radiotherapy (brachytherapy) in the management of prostate cancer!

Keynote Lecture:

‘Incidence and Management of Side Effects of Prostate Brachytherapy’

Speaker: Prof. Stefan Machtens

Hathal Haddad Shares Key Takeaways from the GEC-ESTRO Annual Workshop 2026

An important lecture addressing one of the essential aspects of prostate cancer treatment: balancing excellent oncological outcomes with treatment-related toxicity and quality of life.

Key Clinical Considerations:

  • Patient Selection – Identifying suitable candidates for prostate interventional radiotherapy (brachytherapy).
  • Toxicity Management – Recognizing, preventing, and managing treatment-related urinary, gastrointestinal, and sexual side effects.
  • Quality of Life – Maintaining functional outcomes alongside effective cancer control.
  • Multidisciplinary Collaboration – Strengthening cooperation between urologists, radiation oncologists, and medical physicists.

My Personal Takeaway: The future of prostate cancer treatment depends on collaboration, not competition, between specialties.

Recognizing a urologist who supports interventional radiotherapy (brachytherapy) sends an important message:
The best treatment decisions are made when different specialties work together, placing the patient at the center of every decision.

Congratulations once again to Prof. Stefan Machtens on this well-deserved recognition!
One Patient. One Multidisciplinary Team. One Shared Goal: Better Cancer Care.”

You may also be interested in:

Adam Weiner: ACS Makes Major Shift Toward Routine PSA-Based Prostate Cancer Screening

New Prostate Cancer Screening Guidelines Recommend Regular PSA Testing

Hathal Haddad Shares Key Takeaways from the GEC-ESTRO Annual Workshop 2026